dexamethasone 21-palmitate has been researched along with Hemosiderosis in 2 studies
*Hemosiderosis: Conditions in which there is a generalized increase in the iron stores of body tissues, particularly of liver and the MONONUCLEAR PHAGOCYTE SYSTEM, without demonstrable tissue damage. The name refers to the presence of stainable iron in the tissue in the form of hemosiderin. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Doi, T; Hara, T; Ihara, K; Ishii, K; Ishimura, M; Nagai, H; Ohga, S; Takada, H | 1 |
Ohga, S; Wakiguchi, H | 1 |
1 review(s) available for dexamethasone 21-palmitate and Hemosiderosis
Article | Year |
---|---|
Clinical utility of the liposteroid therapy: Potential effects on the macrophage activation.
Topics: Animals; Arthritis; Dexamethasone; Disease Models, Animal; Graft vs Host Disease; Granuloma; Hemosiderosis; Humans; Hypothalamo-Hypophyseal System; Lung Diseases; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation; Macrophage Activation Syndrome; Pituitary-Adrenal System; Pulse Therapy, Drug; Rats | 2016 |
1 other study(ies) available for dexamethasone 21-palmitate and Hemosiderosis
Article | Year |
---|---|
Long-term liposteroid therapy for idiopathic pulmonary hemosiderosis.
Topics: Child; Child, Preschool; Dexamethasone; Drug Administration Schedule; Female; Glucocorticoids; Hemosiderosis; Hemosiderosis, Pulmonary; Humans; Infant; Infusions, Intravenous; Liposomes; Lung Diseases; Male; Microspheres; Retrospective Studies; Treatment Outcome | 2013 |